Related Experiment Videos
Multidisciplinary management of metastatic sarcoma.
Katherine Thornton1, Catherine E Pesce, Michael A Choti
1Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. kthornt2@jhmi.edu
The Surgical Clinics of North America
|June 3, 2008
Summary
Soft tissue sarcomas are diverse cancers. For select metastatic sarcoma patients, a multidisciplinary team approach using combined treatments offers hope for prolonged survival and potential cure.
Area of Science:
- Oncology
- Malignant Neoplasms
Background:
- Soft tissue sarcomas are a heterogeneous group of cancers originating from mesenchymal tissues.
- Extremities are the most common primary site for sarcoma development.
- Metastatic disease in sarcoma presents a significant clinical challenge, often lacking curative treatment options.
Purpose of the Study:
- To explore the potential of multimodality treatment approaches for select patients with metastatic sarcoma.
- To investigate the role of multidisciplinary team decision-making in optimizing outcomes for metastatic sarcoma.
Main Methods:
- Patient selection based on a careful balance of potential benefit and treatment toxicity.
- Application of a combined multimodality treatment strategy.
Main Results:
- A combined multimodality approach, guided by expert multidisciplinary teams, can offer prolonged survival for select patients with metastatic sarcoma.
- In specific cases, this approach may lead to a cure for metastatic sarcoma.
Conclusions:
- Careful patient selection and a multidisciplinary approach are crucial for managing metastatic sarcoma.
- Combined multimodality treatment holds promise for improving outcomes in carefully selected metastatic sarcoma patients.